A new analysis of nearly 30,000 smokers finds nicotine vaping beats patches, gum and more for quitting, sparking fresh debate over harm reduction.
Singletto, a biotechnology startup based in Seattle, has made headlines as its FDA-approved, virus-neutralizing mask is now available for purchase on Amazon. This advancement follows the company’s recent successes, including U.S. Department of Defense backing and a substantial funding round, signaling a major leap for consumer-accessible advanced PPE.
A Stanford research team has, for the first time, successfully designed and created synthetic virus genomes using artificial intelligence. The new bacteriophages, developed by Professor Brian Hie and colleagues, target E. coli bacteria with higher infectivity than any naturally-occurring viruses, raising major scientific possibilities alongside deep concerns over biosecurity and AI governance.
In a landmark moment for neurotechnology and patient empowerment, Mark Jackson, a patient with amyotrophic lateral sclerosis (ALS), has become the first person in the world to control an iPad solely using his thoughts. The breakthrough was made possible through a brain-computer interface developed by Synchron, a company at the forefront of neural device innovation.